Population pharmacokinetics of peginterferon α2a in patients with chronic hepatitis B

There were significant differences in response and pharmacokinetic characteristics to the peginterferon α2a treatment among Chronic Hepatitis B (CHB) patients. The aim of this study is to identify factors which could significantly impact the peginterferon α2a pharmacokinetic characteristics in CHB p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Jingfeng, Li, Xingang, Liu, Jia, Chen, Dawei, Li, Shuo, Hou, Jun, Zhou, Yuxia, Zhu, Shanwei, Zhao, Zhigang, Qin, Enqiang, Wei, Zhenman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555209/
https://www.ncbi.nlm.nih.gov/pubmed/28801680
http://dx.doi.org/10.1038/s41598-017-08205-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555209/
https://www.ncbi.nlm.nih.gov/pubmed/28801680
http://dx.doi.org/10.1038/s41598-017-08205-5

Ejemplares similares